Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1964 1
1971 2
1972 1
1977 1
1982 1
1983 2
1984 2
1985 1
1986 1
1988 1
1989 1
1990 1
2002 1
2003 1
2015 2
2016 1
2017 2
2018 1
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.
Pasch CA, Favreau PF, Yueh AE, Babiarz CP, Gillette AA, Sharick JT, Karim MR, Nickel KP, DeZeeuw AK, Sprackling CM, Emmerich PB, DeStefanis RA, Pitera RT, Payne SN, Korkos DP, Clipson L, Walsh CM, Miller D, Carchman EH, Burkard ME, Lemmon KK, Matkowskyj KA, Newton MA, Ong IM, Bassetti MF, Kimple RJ, Skala MC, Deming DA. Pasch CA, et al. Among authors: payne sn. Clin Cancer Res. 2019 Sep 1;25(17):5376-5387. doi: 10.1158/1078-0432.CCR-18-3590. Epub 2019 Jun 7. Clin Cancer Res. 2019. PMID: 31175091 Free PMC article.
MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers.
Fricke SL, Payne SN, Favreau PF, Kratz JD, Pasch CA, Foley TM, Yueh AE, Van De Hey DR, Depke MG, Korkos DP, Sha GC, DeStefanis RA, Clipson L, Burkard ME, Lemmon KK, Parsons BM, Kenny PA, Matkowskyj KA, Newton MA, Skala MC, Deming DA. Fricke SL, et al. Among authors: payne sn. Mol Cancer Ther. 2019 Feb;18(2):346-355. doi: 10.1158/1535-7163.MCT-18-0510. Epub 2018 Nov 13. Mol Cancer Ther. 2019. PMID: 30425131 Free PMC article.
Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K.
Yueh AE, Payne SN, Leystra AA, Van De Hey DR, Foley TM, Pasch CA, Clipson L, Matkowskyj KA, Deming DA. Yueh AE, et al. Among authors: payne sn. PLoS One. 2016 Feb 10;11(2):e0148730. doi: 10.1371/journal.pone.0148730. eCollection 2016. PLoS One. 2016. PMID: 26863299 Free PMC article.
Percutaneous absorption of cyclosporin.
Thomson AW, Payne SN. Thomson AW, et al. Among authors: payne sn. Lancet. 1988 Apr 30;1(8592):1000. doi: 10.1016/s0140-6736(88)91822-3. Lancet. 1988. PMID: 2896811 No abstract available.
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
Foley TM, Payne SN, Pasch CA, Yueh AE, Van De Hey DR, Korkos DP, Clipson L, Maher ME, Matkowskyj KA, Newton MA, Deming DA. Foley TM, et al. Among authors: payne sn. Mol Cancer Res. 2017 Feb 9;15(3):317-327. doi: 10.1158/1541-7786.MCR-16-0256. Online ahead of print. Mol Cancer Res. 2017. PMID: 28184015 Free PMC article.
Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
Hope C, Emmerich PB, Papadas A, Pagenkopf A, Matkowskyj KA, Van De Hey DR, Payne SN, Clipson L, Callander NS, Hematti P, Miyamoto S, Johnson MG, Deming DA, Asimakopoulos F. Hope C, et al. Among authors: payne sn. J Immunol. 2017 Sep 1;199(5):1933-1941. doi: 10.4049/jimmunol.1700529. Epub 2017 Jul 28. J Immunol. 2017. PMID: 28754680 Free PMC article.
Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence.
Hadac JN, Leystra AA, Paul Olson TJ, Maher ME, Payne SN, Yueh AE, Schwartz AR, Albrecht DM, Clipson L, Pasch CA, Matkowskyj KA, Halberg RB, Deming DA. Hadac JN, et al. Among authors: payne sn. Cancer Prev Res (Phila). 2015 Oct;8(10):952-61. doi: 10.1158/1940-6207.CAPR-15-0003. Epub 2015 Aug 14. Cancer Prev Res (Phila). 2015. PMID: 26276752 Free PMC article.
Lesions due to complement in lipid membranes.
Hesketh TR, Dourmashkin RR, Payne SN, Humphrey JH, Lachmann PJ. Hesketh TR, et al. Among authors: payne sn. Nature. 1971 Oct 29;233(5322):620-3. doi: 10.1038/233620a0. Nature. 1971. PMID: 4939804 No abstract available.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page